arginine vasopressin has been researched along with quinidine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Civan, MM; Peterson-Yantorno, K; Tang, CS | 1 |
| Hardy, MA; Ware, HM | 1 |
| MOREIRA, MG | 1 |
| BEAULNES, A; BRODEUR, J | 1 |
| BOGGS, ST; CROCKER, HD; HAMLIN, RL; SMETZER, DL; SMITH, CR | 1 |
1 review(s) available for arginine vasopressin and quinidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for arginine vasopressin and quinidine
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Coupling of volume and Na+ transport in frog skin epithelium.
Topics: Amiloride; Animals; Arginine Vasopressin; Cell Membrane; Electric Conductivity; Epithelium; In Vitro Techniques; Kinetics; Membrane Potentials; Models, Biological; Osmolar Concentration; Phlorhizin; Quinidine; Rana pipiens; Skin Physiological Phenomena; Sodium | 1989 |
Roles of Ca2+ and Na+ on the modulation of antidiuretic hormone action on urea permeability in toad urinary bladder.
Topics: Animals; Arginine Vasopressin; Bufo marinus; Calcimycin; Calcium; Carbachol; Cell Membrane Permeability; Diltiazem; Dinitrophenols; Female; Indomethacin; Iodoacetates; Iodoacetic Acid; Monensin; Quinidine; Sodium; Urea; Urinary Bladder | 1985 |
[THE VALUE OF THE BALLISTOCARDIOGRAM IN PHARMACODYNAMICS].
Topics: Amino Alcohols; Amyl Nitrite; Animals; Anti-Arrhythmia Agents; Arginine Vasopressin; Ballistocardiography; Dogs; Epinephrine; Myocardial Infarction; Pharmacology; Quinidine; Renin; Tetraethylammonium Compounds; Vasopressins | 1963 |
[EFFECTS OF SYNTHETIC LYSL-8-VASOPRESSIN ON ADRENALINE-CHLOROFORM ARRHYTHMIAS IN THE ANESTHETIZED DOG].
Topics: Anti-Arrhythmia Agents; Arginine Vasopressin; Arrhythmias, Cardiac; Blood Pressure; Chloroform; Dogs; Electrocardiography; Epinephrine; Peptides; Pharmacology; Quinidine; Research; Toxicology; Vasopressins; Ventricular Fibrillation | 1964 |
EFFECT OF PLV-2, BRADYKININ, QUINIDINE, AND VASOPRESSIN ON MYOCARDIAL CONDUCTION VELOCITY IN DOGS.
Topics: Animals; Arginine Vasopressin; Bradykinin; Dogs; Felypressin; Heart Conduction System; Lysine; Myocardium; Oxytocin; Pharmacology; Phenylalanine; Quinidine; Research; Vasopressins | 1964 |